125 related articles for article (PubMed ID: 21756850)
1. The changing scenario of hepatocellular carcinoma over the last two decades in Italy.
Santi V; Buccione D; Di Micoli A; Fatti G; Frigerio M; Farinati F; Del Poggio P; Rapaccini G; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Giannini EG; Caturelli E; Chiaramonte M; Bernardi M; Trevisani F
J Hepatol; 2012 Feb; 56(2):397-405. PubMed ID: 21756850
[TBL] [Abstract][Full Text] [Related]
2. Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres.
Cazzagon N; Trevisani F; Maddalo G; Giacomin A; Vanin V; Pozzan C; Poggio PD; Rapaccini G; Nolfo AM; Benvegnù L; Zoli M; Borzio F; Giannini EG; Caturelli E; Chiaramonte M; Foschi FG; Cabibbo G; Felder M; Ciccarese F; Missale G; Baroni GS; Morisco F; Pecorelli A; Farinati F;
Liver Int; 2013 Oct; 33(9):1420-7. PubMed ID: 23758775
[TBL] [Abstract][Full Text] [Related]
3. Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
Farinati F; Sergio A; Giacomin A; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Zoli M; Borzio F; Giannini EG; Caturelli E; Trevisani F;
Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1212-8. PubMed ID: 19465859
[TBL] [Abstract][Full Text] [Related]
4. Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma.
Giannini EG; Bodini G; Corbo M; Savarino V; Risso D; Di Nolfo MA; Del Poggio P; Benvegnù L; Farinati F; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Aliment Pharmacol Ther; 2010 Feb; 31(4):493-501. PubMed ID: 19912152
[TBL] [Abstract][Full Text] [Related]
5. Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria.
Takuma Y; Nouso K; Makino Y; Gotoh T; Toshikuni N; Morimoto Y; Shimomura H; Yamamoto H
J Gastroenterol Hepatol; 2011 Sep; 26(9):1417-24. PubMed ID: 21884248
[TBL] [Abstract][Full Text] [Related]
6. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
Yang JD; Harmsen WS; Slettedahl SW; Chaiteerakij R; Enders FT; Therneau TM; Orsini L; Kim WR; Roberts LR
Clin Gastroenterol Hepatol; 2011 Jul; 9(7):617-23.e1. PubMed ID: 21459158
[TBL] [Abstract][Full Text] [Related]
7. The evolutionary scenario of hepatocellular carcinoma in Italy: an update.
Bucci L; Garuti F; Lenzi B; Pecorelli A; Farinati F; Giannini EG; Granito A; Ciccarese F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Sacco R; Cammà C; Virdone R; Marra F; Felder M; Morisco F; Benvegnù L; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Missale G; Masotto A; Nardone G; Colecchia A; Bernardi M; Trevisani F;
Liver Int; 2017 Feb; 37(2):259-270. PubMed ID: 27427866
[TBL] [Abstract][Full Text] [Related]
8. Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience.
Mirici-Cappa F; Gramenzi A; Santi V; Zambruni A; Di Micoli A; Frigerio M; Maraldi F; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M; Trevisani F;
Gut; 2010 Mar; 59(3):387-96. PubMed ID: 20207642
[TBL] [Abstract][Full Text] [Related]
9. Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000: analysis of 1365 patients in a single institution in Japan.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Hayashi K; Honda T; Kitabatake S; Kuzuya T; Nonogaki K; Kasugai T; Shimizu J
Cancer; 2004 Jun; 100(11):2415-21. PubMed ID: 15160346
[TBL] [Abstract][Full Text] [Related]
10. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and prognosis of patients with hepatocellular carcinoma after the year 2000 in Japan.
Toyoda H; Kumada T; Tada T; Sone Y; Kaneoka Y; Maeda A
J Gastroenterol Hepatol; 2011 Dec; 26(12):1765-71. PubMed ID: 21615793
[TBL] [Abstract][Full Text] [Related]
12. The changing scenario of hepatocellular carcinoma in Italy: an update.
Garuti F; Neri A; Avanzato F; Gramenzi A; Rampoldi D; Rucci P; Farinati F; Giannini EG; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Sacco R; Cabibbo G; Marra F; Mega A; Morisco F; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Missale G; Masotto A; Nardone G; Raimondo G; Azzaroli F; Vidili G; Brunetto MR; Trevisani F;
Liver Int; 2021 Mar; 41(3):585-597. PubMed ID: 33219585
[TBL] [Abstract][Full Text] [Related]
13. Changing paradigm in the management of hepatocellular carcinoma improves the survival benefit of early detection by screening.
Chan AC; Poon RT; Ng KK; Lo CM; Fan ST; Wong J
Ann Surg; 2008 Apr; 247(4):666-73. PubMed ID: 18362630
[TBL] [Abstract][Full Text] [Related]
14. Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.
Trevisani F; Magini G; Santi V; Morselli-Labate AM; Cantarini MC; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M;
Am J Gastroenterol; 2007 May; 102(5):1022-31. PubMed ID: 17313497
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma in western Sydney. Aetiology, changes in incidence, and opportunities for better outcomes.
Brotodihardjo AE; Tait N; Weltman MD; Liddle C; Little JM; Farrell GC
Med J Aust; 1994 Oct; 161(7):433-5. PubMed ID: 7935098
[TBL] [Abstract][Full Text] [Related]
16. Impact of surveillance on survival of patients with initial hepatocellular carcinoma: a study from Japan.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1170-6. PubMed ID: 16890027
[TBL] [Abstract][Full Text] [Related]
17. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma downstaging in liver transplantation.
Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
[TBL] [Abstract][Full Text] [Related]
20. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P
Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
